Skip to main content
. 2026 May 6;62(5):891. doi: 10.3390/medicina62050891
OLP Oral lichen planus
CP Calprotectin
sCP Serum calprotectin
OLP-DAS Oral Lichen Planus Disease Activity Scale
CRP C-reactive protein
ESR Erythrocyte sedimentation rate
LDH Lactate dehydrogenase
AUC Area under the curve
HLA Human leukocyte antigen
MMP Matrix metalloproteinase
EBV Epstein–Barr virus
VZV Varicella zoster virus
HHV Human herpesvirus
HPV Human papillomavirus
HCV Hepatitis C virus
DM Diabetes mellitus
IBD Inflammatory bowel disease
WHO World Health Organization
AAOMP American Academy of Oral and Maxillofacial Pathology
OLR Oral lichenoid reaction
OPMD Oral potentially malignant disorder
ODSS Oral Disease Severity Score
REU Reticular-Erythema-Ulcerative
DAMP Damage-associated molecular pattern
fCP Faecal calprotectin
IBS Irritable bowel syndrome
NSAID Non-steroidal anti-inflammatory drug
DMARD Disease-modifying antirheumatic drug
G-CSF Granulocyte colony-stimulating factor
LP Lichen planus
PETIA Particle-enhanced turbidimetric immunoassay
OLP-IGA Oral Lichen Planus-Investigator Global Assessment
OLP-SI Oral Lichen Planus-Severity Index
OLP-SS Oral Lichen Planus-Sign Score
NRS Numerical rating scale
ANOVA Analysis of variance
SD Standard deviation
IQR Interquartile range
N Number
M Male
F Female
ROC Receiver Operating Characteristic curve
GI Gastrointestinal
Lkc Leukocyte
IL-6 Interleukin 6